about InsuJet TM
See all >
Type 1 & 2
Most InsuJet™ users
recommend using it to others.
The portable InsuJetTM V5 is ideal for self-injection. The InsuJetTM package contains the reusable injector, a sturdy Carry Case, an Instructions For Use booklet and a warranty card. Besides the injector you will require reusable InsuJetTM Nozzles, 3mL or 10mL Adaptors for your insulin, and your prescribed type of insulin to start using the system. Nozzles and Adaptors are sold separately.
A closer look
Needle-phobia is real.
Needle-free advantages too.
say about InsuJet™
Needlestick injuries can be caused through unsafe procedures, difficult working conditions and unsafe devices. InsuJetTM can help prevent needle stick injuries for medical professionals.
In Germany an average of 50.3% (n = 492/978) of all needlestick injuries could have been avoided by the use of safety devices, whereas only 15.2% could have been prevented by organizational measures. In a study, 31.5% (n = 503/1598) of participant healthcare workers had sustained at least one needlestick injury in the past twelve months. The rate of underreporting was about 75%. After introduction of safety devices, 91.8% of the healthcare workers reported being satisfied with the anti-needlestick devices and 83.4% believed that safety devices would increase the safety of the work environment.
Occupational exposure to blood is a common problem among healthcare workers.
The introduction of Needle-free is one of the main starting points for avoidance of needlestick injuries, and acceptance among healthcare workers is high.
Further targets for preventive measures, such as training in safe working routines, are necessary for improvement of safe work conditions***.
The InsuJet™ is suitable for most diabetics who require insulin therapy, and this includes both type 1 and type 2 diabetes. Clinical studies have been conducted with similar results in both type 1 and 2 patients. There was no indication that the jet injector performed differently in patients with type 1 and type 2 diabetes.
Please note that it is advised to involve your Diabetes Care Specialist if you consider using the InsuJet™ device.
For more information please visit our Partner pages.
Suitability for lay users:
81% of users has no problems during first time use. And the remaining others have little to no-trouble after consulting the instructions for use.
96% of the respondents in a user survey found the InsuJet™ pleasant, user friendly and an efficient method of insulin administration, and over 78% would recommend the InsuJet™ systems to others.
In the survey, 70% of the users reported that they noticed faster insulin absorption.
As there are many insurance providers, it is advised to check directly with your insurance provider whether your insurance covers the InsuJet™ insulin-administration system.
If your insurance provider needs more information regarding the InsuJet, please contact us, and we can share the relevant information with you, or directly with your insurance provider.
Contact us >
01. Compatible insulin types: Human and animal; Fast acting insulins (bolus); Rapid Acting Insulin Analogs; Regular Human Insulin; Basal insulins; Intermediate-acting, commonly: NPH/ Isophane; Long-acting, commonly: Glargine, detemir, degludec; Premixtures (e.g. 30/70).
02. In a user survey, 78% of respondents answered they would recommend InsuJet™ to others.
03. In a user survey, 40% of the respondents answered they noticed using less insulin.
04. Needle-Free Jet Injection of Rapid-Acting Insulin Improves Early Postprandial Glucose Control in Patients With Diabetes. Diabetes Care, October 2013.
05. Body mass index and the efficacy of needle-free jet injection for the administration of rapid-acting insulin analogs, a post hoc analysis. Diabetes, Obesity and Metabolism, July 2012.
06. Improved Pharmacokinetic and Pharmacodynamic Profile of Rapid-Acting Insulin Using Needle-Free Jet Injection Technology. Diabetes Care, August 2011
07. A Pilot Study to Examine the Tolerability and Device Preference in Type 1 Diabetes of Insulin Apart Administered by InsuJet™ Compared with Subcutaneous Injection. Diabetes Technology & Therapeutics, 2014.
08. See medical deck Cost Analysis - North America, 2022 available on the Partner page.
09. Calculated at 4 injections a day with a hypodermic needle. 4 injection a day, every day of the year, adds up to 1,460 needles a year saved from use.
*. The InsuJet™ is calibrated for U-100 insulins
**. Needle gauge 26-27 is commonly used for subcutaneous injections and is around 0.40 - 0.45mm in diameter. The orifice of the InsuJet™ Nozzle is about 0.15mm in diameter which is much smaller than conventional needle gauges used for subcutaneous insulin injections.
***. https://pubmed.ncbi.nlm.nih.gov PMID:18820853